Authors
    • Robert Henry Levi and Ryda Hecht Levi Professor of Bioethics and Public Policy at Johns Hopkins Berman Institute of Bioethics
    Jeffrey Kahn, PhD, MPH, is the inaugural Robert Henry Levi and Ryda Hecht Levi Professor of Bioethics and Public Policy at the Johns Hopkins Berman Institute of Bioethics. He works in a variety of areas of bioethics, exploring the intersection of ethics and health/science policy, including human and animal research ethics, public health, and ethical issues in emerging biomedical technologies. Prof. Kahn has served on numerous state and federal advisory panels, and he is currently chair of the Institute of Medicine (IOM) Board on Health Sciences Policy. He is co-principal investigator on an NIH “Center of Excellence” project to study the ethical, legal and social implications (ELSI) of genomic research examining the largely unexplored but crucial study of genomics as applied to infectious disease. He was the founding president of the Association of Bioethics Program Directors, a position he held from 2006-2010, and is an elected Fellow of The Hastings Center. Prof. Kahn has published three books and over 120 articles in the bioethics and medical literature, and speaks frequently across the US and around the world on a range of bioethics topics. Prior to joining the faculty at Johns Hopkins, Prof. Kahn was Director of the Center for Bioethics at the University of Minnesota. His education includes a BA from UCLA, PhD from Georgetown University, and MPH from the Johns Hopkins Bloomberg School of Public Health.
    • Clinical Genetics (MD)
    • Pediatrics
    • Mitochondrial Disease; Human Genetics
    Clinical Geneticist at Children's Hospital of Philadelphia and University of Pennsylvania School of Medicine, Philadelphia, PA
    Clinical Geneticist at Children's Hospital of Philadelphia and University of Pennsylvania School of Medicine, Philadelphia, PA
    Marni J. Falk, M.D., received her B.S. degree in biology and her medical degree in a combined 7-year program from the George Washington University School of Medicine. She then completed dual specialty training in a combined 5-year pediatrics and clinical genetics residency program at Case Western Reserve University and University Hospital of Cleveland in Cleveland, Ohio. She has been assistant professor since 2006 in the Division of Human Genetics in the Department of Pediatrics at The Children's Hospital of Philadelphia (CHOP) and University of Pennsylvania (UPenn) Perelman School of Medicine. Board certified in clinical genetics and pediatrics, Dr. Falk established and directs the CHOP Mitochondrial-Genetics Diagnostic Clinic to aid in the evaluation and management of individuals of all ages with suspected mitochondrial disease. She is actively involved in developing improved diagnostic approaches and resources for mitochondrial disease, including organization of a global Mitochondrial Disease Sequence Data Resource (MSeqDR) consortium. Dr. Falk is principal investigator for an NIH-funded translational research laboratory at CHOP that investigates the causes and global metabolic consequences of mitochondrial disease, as well as targeted pharmacologic therapies, in C. elegans, zebrafish, mouse, and human tissue models of genetic and pharmacologic-based respiratory chain dysfunction. She has authored more than 70 publications in the areas of human genetics and mitochondrial disease. Dr. Falk also organized and directs the CHOP/Penn Mitochondria Research Affinity Group. She is a member and former chair of the Scientific and Medical Advisory Board and former Board of Trustees member of the United Mitochondrial Disease Foundation; a member of the Scientific Advisory Board of the nonprofit Genesis Project; a founding member of the CHOP Center for Mitochondrial and Epigenomic Medicine; CHOP-site principal investigator for the North American Mitochondrial Disease Consortium; a member of the Mitochondrial Congressional Caucus, Mitochondrial Medicine Society, Mitochondrial Research Society, Society for Pediatric Research, Society of Inherited Metabolic Disease, and American Society of Human Genetics; and a fellow of the American College of Medical Genetics and Genomics. She served as a committee member on the Institute of Medicine Committee on the Ethical and Social Policy Considerations of Novel Techniques for Prevention of Maternal Transmission of Mitochondrial DNA Diseases.